CG logo

Carlyle (CG) EBITDA

Annual EBITDA

$122.60 M
-$1.92 B-94.00%

December 31, 2023


Summary


Performance

CG EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCGprofitabilitymetrics:

Quarterly EBITDA

$1.03 B
+$580.50 M+129.92%

September 1, 2024


Summary


Performance

CG Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCGprofitabilitymetrics:

TTM EBITDA

$1.15 B
+$692.30 M+151.52%

September 1, 2024


Summary


Performance

CG TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCGprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CG EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-94.0%+219.6%+882.2%
3 y3 years-86.2%+219.6%+882.2%
5 y5 years-81.3%+219.6%+882.2%

CG EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-97.2%at lowat high+258.9%-73.7%+882.2%
5 y5-year-97.2%at low-23.2%+245.3%-73.7%>+9999.0%
alltimeall time-97.2%at low-40.4%+245.3%-73.7%>+9999.0%

Carlyle EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.03 B(+129.9%)
$1.15 B(+151.5%)
Jun 2024
-
$446.80 M(+39.0%)
$456.90 M(+290.5%)
Mar 2024
-
$321.40 M(-149.7%)
$117.00 M(-4.6%)
Dec 2023
$122.60 M(-94.0%)
-$646.30 M(-292.9%)
$122.60 M(-88.7%)
Sep 2023
-
$335.00 M(+213.4%)
$1.09 B(-11.9%)
Jun 2023
-
$106.90 M(-67.3%)
$1.24 B(-19.6%)
Mar 2023
-
$327.00 M(+2.5%)
$1.54 B(-24.8%)
Dec 2022
$2.04 B(-53.3%)
$319.10 M(-33.9%)
$2.04 B(-25.1%)
Sep 2022
-
$482.40 M(+18.3%)
$2.73 B(-10.1%)
Jun 2022
-
$407.70 M(-51.0%)
$3.03 B(-23.5%)
Mar 2022
-
$832.70 M(-16.9%)
$3.96 B(-9.4%)
Dec 2021
$4.37 B(+391.4%)
$1.00 B(+27.3%)
$4.37 B(+5.5%)
Sep 2021
-
$787.50 M(-41.1%)
$4.14 B(+7.8%)
Jun 2021
-
$1.34 B(+7.6%)
$3.84 B(+35.3%)
Mar 2021
-
$1.24 B(+60.8%)
$2.84 B(+219.2%)
Dec 2020
$889.60 M(-41.2%)
$772.90 M(+58.3%)
$889.60 M(+484.9%)
Sep 2020
-
$488.20 M(+45.6%)
$152.10 M(-3480.0%)
Jun 2020
-
$335.40 M(-147.4%)
-$4.50 M(-101.7%)
Mar 2020
-
-$706.90 M(-2096.9%)
$263.10 M(-82.6%)
Dec 2019
$1.51 B(+131.4%)
$35.40 M(-89.3%)
$1.51 B(+2.6%)
Sep 2019
-
$331.60 M(-45.0%)
$1.47 B(+15.0%)
Jun 2019
-
$603.00 M(+11.1%)
$1.28 B(+27.3%)
Mar 2019
-
$542.90 M(<-9900.0%)
$1.01 B(+54.0%)
Dec 2018
$653.90 M(-60.1%)
-$3.60 M(-102.6%)
$653.90 M(-41.4%)
Sep 2018
-
$139.80 M(-57.3%)
$1.12 B(-12.2%)
Jun 2018
-
$327.70 M(+72.5%)
$1.27 B(-3.0%)
Mar 2018
-
$190.00 M(-58.6%)
$1.31 B(-20.0%)
Dec 2017
$1.64 B
$459.20 M(+55.5%)
$1.64 B(+24.4%)
DateAnnualQuarterlyTTM
Sep 2017
-
$295.30 M(-19.6%)
$1.32 B(+17.5%)
Jun 2017
-
$367.20 M(-29.0%)
$1.12 B(+19.6%)
Mar 2017
-
$517.50 M(+277.2%)
$937.00 M(+82.0%)
Dec 2016
$514.70 M(-73.8%)
$137.20 M(+39.0%)
$514.70 M(-5.2%)
Sep 2016
-
$98.70 M(-46.2%)
$542.70 M(+16.3%)
Jun 2016
-
$183.60 M(+92.9%)
$466.80 M(-57.0%)
Mar 2016
-
$95.20 M(-42.4%)
$1.08 B(-44.9%)
Dec 2015
$1.97 B(-19.9%)
$165.20 M(+624.6%)
$1.97 B(-2.5%)
Sep 2015
-
$22.80 M(-97.2%)
$2.02 B(-19.3%)
Jun 2015
-
$801.30 M(-18.0%)
$2.50 B(-3.1%)
Mar 2015
-
$977.60 M(+353.4%)
$2.58 B(+5.0%)
Dec 2014
$2.46 B(-4.7%)
$215.60 M(-57.3%)
$2.46 B(-24.5%)
Sep 2014
-
$505.00 M(-42.7%)
$3.26 B(+7.6%)
Jun 2014
-
$880.90 M(+3.0%)
$3.03 B(+13.0%)
Mar 2014
-
$855.50 M(-15.6%)
$2.68 B(+3.8%)
Dec 2013
$2.58 B(-22.6%)
$1.01 B(+268.7%)
$2.58 B(+33.1%)
Sep 2013
-
$275.00 M(-48.3%)
$1.94 B(-22.5%)
Jun 2013
-
$532.10 M(-29.7%)
$2.50 B(+5.8%)
Mar 2013
-
$756.50 M(+102.7%)
$2.36 B(-29.1%)
Dec 2012
$3.33 B(+87.1%)
$373.20 M(-55.4%)
$3.33 B(-13.9%)
Sep 2012
-
$836.50 M(+111.3%)
$3.87 B(+51.6%)
Jun 2012
-
$395.80 M(-77.1%)
$2.55 B(-2.3%)
Mar 2012
-
$1.72 B(+89.7%)
$2.61 B(+46.7%)
Dec 2011
$1.78 B(+1.4%)
$909.10 M(-289.4%)
$1.78 B(+104.4%)
Sep 2011
-
-$480.00 M(-205.2%)
$870.50 M(-35.5%)
Jun 2011
-
$456.40 M(-49.0%)
$1.35 B(+51.0%)
Mar 2011
-
$894.10 M
$894.10 M
Dec 2010
$1.76 B(+137.7%)
-
-
Dec 2009
$738.30 M
-
-

FAQ

  • What is Carlyle annual EBITDA?
  • What is the all time high annual EBITDA for Carlyle?
  • What is Carlyle annual EBITDA year-on-year change?
  • What is Carlyle quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Carlyle?
  • What is Carlyle quarterly EBITDA year-on-year change?
  • What is Carlyle TTM EBITDA?
  • What is the all time high TTM EBITDA for Carlyle?
  • What is Carlyle TTM EBITDA year-on-year change?

What is Carlyle annual EBITDA?

The current annual EBITDA of CG is $122.60 M

What is the all time high annual EBITDA for Carlyle?

Carlyle all-time high annual EBITDA is $4.37 B

What is Carlyle annual EBITDA year-on-year change?

Over the past year, CG annual EBITDA has changed by -$1.92 B (-94.00%)

What is Carlyle quarterly EBITDA?

The current quarterly EBITDA of CG is $1.03 B

What is the all time high quarterly EBITDA for Carlyle?

Carlyle all-time high quarterly EBITDA is $1.72 B

What is Carlyle quarterly EBITDA year-on-year change?

Over the past year, CG quarterly EBITDA has changed by +$705.90 M (+219.63%)

What is Carlyle TTM EBITDA?

The current TTM EBITDA of CG is $1.15 B

What is the all time high TTM EBITDA for Carlyle?

Carlyle all-time high TTM EBITDA is $4.37 B

What is Carlyle TTM EBITDA year-on-year change?

Over the past year, CG TTM EBITDA has changed by +$1.03 B (+882.22%)